Experienced in Necrotizing Fasciitis

Marcus D. Jager

St. Marien Hospital
Muelheim, NW, DE 
Experienced in Necrotizing Fasciitis
St. Marien Hospital
Muelheim, NW, DE 
OverviewLocationsClinical Research

Overview

Marcus Jager practices in Muelheim, Germany. Mr. Jager is rated as an Experienced expert by MediFind in the treatment of Necrotizing Fasciitis. His top areas of expertise are Osteonecrosis, Kienbock's Disease, Osteolysis Syndrome Recessive, Hip Replacement, and Osteotomy.

His clinical research consists of co-authoring 245 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Necrotizing Fasciitis.

Gender
Male

Locations

St. Marien Hospital
Muelheim, NW 45468, Germany
Other Locations
Duisburg, NW, Germany
Essen, NW, Germany
Freiburg, BW, Germany
Oldenburg, NI, Germany
Dortmund, NW, Germany
St. Vinzenz Krankenhaus, Schloßstraße 85, Duesseldorf, NW 40477, Germany
Goettingen, NI 37077, Germany
Hannover, NI 30625, Germany
Berlin, BE, Germany
Ulm, BW, Germany
Munich, BY 80336, Germany
Tuttlingen, BW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Randomised Prospective Multicenter Longterm-Evaluation of the Survival Rate of the Implant, Wear and Periprosthetic Osteolysis of Highly Cross-linked Polyethylene With and Without Addition of Vitamin E (UHMWPE-XE vs. UHMWPE-X)
Randomised Prospective Multicenter Longterm-Evaluation of the Survival Rate of the Implant, Wear and Periprosthetic Osteolysis of Highly Cross-linked Polyethylene With and Without Addition of Vitamin E (UHMWPE-XE vs. UHMWPE-X)
Enrollment Status: Active_not_recruiting
Publish Date: May 02, 2025
Intervention Type: Device
Post Market Clinical Follow-Up Study of the EVOLUTION® Total Knee Arthroplasty System With Cruciate Sacrificing Inserts
Post Market Clinical Follow-Up Study of the EVOLUTION® Total Knee Arthroplasty System With Cruciate Sacrificing Inserts
Enrollment Status: Active_not_recruiting
Publish Date: October 13, 2022
Intervention Type: Device
Post Market Clinical Follow-up Study Protocol for PROFEMUR® Xm Femoral Stems
Post Market Clinical Follow-up Study Protocol for PROFEMUR® Xm Femoral Stems
Enrollment Status: Terminated
Publish Date: April 28, 2022
Intervention Type: Device
View 2 Less Clinical Trials

242 Total Publications

Intraoperative Biologization of β-TCP and PCL-TCP by Autologous Proteins.
Intraoperative Biologization of β-TCP and PCL-TCP by Autologous Proteins.
Journal: Journal of functional biomaterials
Published: July 31, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Jager's expertise for a condition
ConditionClose
    View All 25 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile